Balyasny Asset Management LLC Axsome Therapeutics, Inc. Transaction History
Balyasny Asset Management LLC
- $61.9 Billion
- Q2 2025
A detailed history of Balyasny Asset Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 5,100 shares of AXSM stock, worth $679,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,100
Previous 2,700
88.89%
Holding current value
$679,065
Previous $314,000
69.43%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AXSM
# of Institutions
412Shares Held
37.4MCall Options Held
710KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA3.95MShares$525 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$439 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$225 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$202 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$151 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.71B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...